A Clearer Window Into Disease: Meet the Opera Phenix Microscope
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
40 Results
Clear Filters
Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Showing Up for Science: Celebrities and Stem Cells Take Center Stage at the NYSCF Gala
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
Does Brain Inflammation Trigger Neurodegeneration? If So, it Could Open the Door for New Therapies
Today, more than 6 million Americans suffer from neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis, and as our society ages, that number is only...
NYSCF Scientists Create the ‘Stars’ of the Brain and Capture Their Rogue Behavior in Disease
Read the press release here. You may not have heard of astrocytes before, but your body is full of them: they make up more than...
When Astrocytes Attack: Stem Cell Model Shows Possible Mechanism Behind Neurodegeneration
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
New Hope for Alzheimer’s: Scientists and Clinicians Present Emerging Therapies for a Notoriously Challenging Disease
Alzheimer’s remains one of the most devastating diseases in the world, and though there are more than 44 million people with it worldwide, there are still...
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
NYSCF, Johns Hopkins, and Bloomberg Philanthropies Partner to Advance Precision Medicine
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine (JHUSOM), and Bloomberg Philanthropies is aiming to push precision medicine forward using...
Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
Alzheimer’s Stem Cells are Uncovering Disease Mechanisms, and NYSCF is Making Them Widely Available to the Research Community
One of the great advantages of stem cells is that they can be used to make personalized models of disease — they let us study exactly...
To Make New Neurons, Alzheimer’s-Affected Brains Need to do Some Cleaning
The Context: Alzheimer’s-affected brains do not make new neurons out of neural stem cells as efficiently as healthy brains, and this is an early sign of...
CRISPR to the RESCUE: Gene Editing Technology Gets More Versatile
The Context: CRISPR is a powerful gene editing tool which traditionally works by locating and modifying stretches of DNA within the genome. However, this technique creates...
Stem Cells, Alzheimer’s, and Caregiving: Susan L. Solomon Guests Stars on the “Thank You Dan and Alex” Podcast
“Stem cells allow us to understand what exactly is broken, and therefore, what needs to be fixed,” NYSCF CEO Susan L. Solomon explained. “The problem with...
NYSCF Hosts Panel Discussion on the Future of Alzheimer’s Research and Treatment
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
New York Stem Cell Foundation Research Institute and Tufts University to Collaborate on Neurodegeneration
Scientific teams will develop advanced stem cell models to improve understanding and treatment of Parkinson’s, Alzheimer’s, and similar diseases New York, NY (September 12, 2018) –...
2017 Year in Review
As we enter 2018, NYSCF is taking a moment to look back on the milestones of 2017. With your support, we accelerated our research, began new...
NYSCF and Mount Sinai Researchers Recapitulate Alzheimer’s Disease in the Laboratory
NYSCF Research Institute scientists in collaboration with researchers at the Icahn School of Medicine at Mount Sinai refined a technique to turn skin cells from patients...
NYSCF Innovators Derive Microglia From Stem Cells
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
Visual Stimulation Treats Alzheimer’s Plaques in Mice
NYSCF – Robertson Neuroscience Investigator Dr. Ed Boyden and his team at MIT Media Lab published their latest work on an exciting new, noninvasive approach to treating...
NYSCF Research Institute and Yumanity Therapeutics Announce Discovery Collaboration
The NYSCF Research Institute announced a new collaboration with Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfiling, to generate...
New Type of Stem Cells that Accelerate Discovery
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
NYSCF Quoted in The Wall Street Journal on Experimental Alzheimer’s Drug Testing
Bringing treatments out of laboratories and into clinics remains a major obstacle for healthcare. Mice and other common lab animals cannot reliably predict human responses to...
Visiting NYSCF Researcher Studies The Role of Vitamin B1 in Alzheimer’s Disease
Dr. Gary Gibson, Director of the Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration at Weill Cornell Medical College, joined NYSCF as a visiting scientist...
NYSCF Featured Speaker at Alzheimer’s Disease Conference
Dr. Scott Noggle, NYSCF Vice President for Stem Cell Research, presented NYSCF’s latest Alzheimer’s disease research as the keynote speaker at the Alzheimer’s Disease Resource Center’s...